Jason Kelly
2021
In 2021, Jason Kelly earned a total compensation of $380.7M as Chief Executive Officer at Ginkgo Bioworks Holdings, a 3,515% increase compared to previous year.
Compensation breakdown
| Salary | $250,000 |
|---|---|
| Stock Awards | $380,479,776 |
| Other | $12,500 |
| Total | $380,742,276 |
Kelly received $380.5M in stock awards, accounting for 100% of the total pay in 2021.
Kelly also received $250K in salary and $12.5K in other compensation.
Rankings
In 2021, Jason Kelly's compensation ranked 10th out of 12,415 executives tracked by ExecPay. In other words, Kelly earned more than 99.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 10 out of 12,415 | 100th |
Division Manufacturing | 3 out of 5,505 | 100th |
Major group Chemicals And Allied Products | 1 out of 2,375 | 100th |
Industry group Drugs | 1 out of 2,096 | 100th |
Industry Biological Products, Except Diagnostic Substances | 1 out of 449 | 100th |
Source: SEC filing on April 26, 2022.
Kelly's colleagues
We found two more compensation records of executives who worked with Jason Kelly at Ginkgo Bioworks Holdings in 2021.